Dong-A University is a private university in Busan, South Korea. It is the only private university and one of two universities that has both a medical school and a law school in Busan, the second-largest city in South Korea.

During the past decade, Department of Internal Medicine,Dong-A University College of Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Internal Medicine,Dong-A University College of Medicine" #1 sponsor was "Dong-A University" with 5 trials, followed by "Asan Medical Center" with 1 trials sponsored, "Inje University" with 1 trials sponsored, "National Cancer Center, Korea" with 1 trials sponsored and "Seoul National University Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Internal Medicine,Dong-A University College of Medicine" #1 collaborator was "Ajou University School of Medicine" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Chonbuk National University Hospital" with 1 trials as a collaborator and "Chonnam National University Hospital" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Department of Internal Medicine,Dong-A University College of Medicine" are "Acute Coronary Syndrome" (1 trials), "Ankylosing Spondylitis" (1 trials), "Atrial Fibrillation" (1 trials), "Chronic Hepatitis B" (1 trials) and "Dilated Cardiomyopathy" (1 trials). Many other conditions were trialed in "Department of Internal Medicine,Dong-A University College of Medicine" in a lesser frequency.

Most popular intervention types in "Department of Internal Medicine,Dong-A University College of Medicine" are "Drug" (6 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin with P2Y12 receptor inhibitor" (1 trials), "Carvedilol" (1 trials), "Clopidogrel" (1 trials), "Entecavir" (1 trials) and "FDG PET" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Internal Medicine,Dong-A University College of Medicine" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Department of Internal Medicine,Dong-A University College of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Internal Medicine,Dong-A University College of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Internal Medicine,Dong-A University College of Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".